ITGAM and familial pancreatic carcinoma: Using our TME model of pancreatic cancer, we aimed to compare cell functions within starPEG–heparin hydrogels and commonly used collagen matrices and to evaluate cell responses toward the novel CD11b agonist ADH‐503 in combination with αPD‐1 treatment and standard‐of‐care chemotherapy.